Investors
Scancell Holdings PLC is an AIM listed company
Latest News
Scancell to present positive Phase 2 data on Immunobody® iSCIB1+ in late-stage melanoma at SITC 2025
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Results of 2025 Annual General Meeting
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
